A 5020New Jersey
Prohibits pharmacy benefit manager from using spread pricing as model of prescription drug pricing; requires transparency in provision of pharmacy benefits management services.
In committee
May 7, 2026: Introduced, Referred to Assembly Financial Institutions and Insurance Committee